User:MWV152471HXU/CPEB
 | This is the sandbox page where you will draft your initial Wikipedia contribution.
If you're starting a new article, you can develop it here until it's ready to go live. If you're working on improvements to an existing article, copy only one section at a time of the article to this sandbox to work on, and be sure to use an edit summary linking to the article you copied from. Do not copy over the entire article. You can find additional instructions here. Remember to save your work regularly using the "Publish page" button. (It just means 'save'; it will still be in the sandbox.) You can add bold formatting to your additions to differentiate them from existing content. |
| Cytoplasmic polyadenylation element binding protein | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Properties of CPEBs and their interactions with other proteins in RNP complexes | |||||||||
| Identifiers | |||||||||
| Symbol | CPEB | ||||||||
| Pfam | PF16366 | ||||||||
| InterPro | IPR034819 | ||||||||
| |||||||||
CPEB, or cytoplasmic polyadenylation element (CPE) binding protein, is a highly conserved RNA-binding protein that promotes the elongation of the
polyadenine tail of messenger RNA.[1] CPEB is present at postsynaptic sites and dendrites where it stimulates polyadenylation and translation in response to synaptic activity.[2] CPEB most commonly activates the target RNA for translation, but can also act as a repressor,[3] dependent on its phosphorylation state.[4] As a repressor, CPEB interacts with the deadenylation complex and shortens the polyadenine tail of mRNAs.[5] In animals, CPEB is expressed in several alternative splicing isoforms that are specific to particular tissues and functions, including the self-cleaving Mammalian CPEB3 ribozyme. CPEB was first identified in Xenopus oocytes and associated with meiosis;[1] a role has also been identified in the spermatogenesis of Caenorhabditis elegans.[6]
CPEB is involved in closed-loop regulation of mRNAs that keeps them inactive. The closed-loop structure between the 3'UTR and 5'UTR inhibits translation.[7] This has been observed in Xenopus laevis in which eIF4E bound to the 5' cap interacts with Maskin bound to CPEB on the 3' UTR creating translationally inactive transcripts. This translational inhibition is lifted once CPEB is phosphorylated, displacing the Maskin binding site, allowing for the polymerization of the PolyA tail, which can recruit the translational machinery by means of PABP.[8] However, it is important to note that this mechanism has been under great scrutiny.[9]
CPEB has been shown to shuttle between the nucleus and cytoplasm.[10] In the nuclei of different organisms, it was found that CPEB universally helps guide the path of mRNA in the cytoplasm. CPEB was found to be almost exclusively in the cytoplasm in stage VI Xenopus oocytes.[1] However, a further study on this topic found that there is a substantial amount of CPEB in the nucleus.[10] CPEB can bind with CPE-containing mRNAs in the nucleus, which forces tight translational regulation in the cytoplasm. CPEBs bound to these mRNAs were found to have lower translation efficiency, which is indicative of the translation regulation.
Protein Family
[edit]CPEB can also refer to the family of proteins[11]. There are four proteins in the protein family:
- CPEB1
- CPEB2
- CPEB3
- CPEB4
This protein family can be divided into two subfamilies. The groups are separated by their "...specific properties in target/motif recognition, large-order complex co-factors, and dynamic properties and regulation during cell cycle."[12] The first subfamily contains only CPEB1 and the second contains CPEB2 - CPEB4. The general CPE that CPEBs bind to has a canonical UUUUAU sequence, which all four of the proteins can recognize. However, CPEB1 can only recognize CPEs with the canonical sequence, while the second group of CPEB2–4 can also bind to variants of the CPE, known as G-variants due to their sequence difference (UUUUGU). This suggests that CPEB2–4 has other targets that it can hit in addition to CPEB1 targets. 20% of the genes in the human genome can be CPEB1 targets.[13] The proteins can also coexist inside cells.
Structure
[edit]The CPEB structure consists of "...an amino-terminal portion with no obvious functional motif, two RNA recognition motifs (RRMS), and a cysteine-histidine region that is reminiscent of a zinc finger."[14] The zinc finger region and RRMs are necessary for RNA binding. It was found that CPEB bound to other metals than zinc destroyed RNA binding, but the binding would be restored if supplemented with zinc.[14] Proteins lacking any of the RRMs were also shown to be less efficient in binding RNA.
Not all of the regions are the same across the different forms of CPEB. The amino terminus can differ substantially across the proteins. The prion-like isoform of CPEB found in Aplysia californica, Drosophila, mice, and humans is an example of such differentiation. This isoform is prion-like due to the presence of polyglutamine- or polyalanine-rich domains at the N-terminus.[5]
Neurological Disorders
[edit]A misstep in the process of translation with CPEB can lead to possible adverse affects on neurological development. Risk genes for autism spectrum disorder were found in brains where "...CPEB4 transcript isoform imbalance due to decreased inclusion of a neuronal-specific microexon together with a new molecular signature of global polyadenine tail shortening..."[15] In idiopathic autism spectrum disorder individuals, CPEB4 is greatly decreased and showed significant splicing alterations. An equivalent isoform imbalance in mice mimics changes of autism spectrum disorder genes, which causes similar neuroanatomical, electrophysiological, and behavioral phenotype expression.
Gene regulation of CPEB proteins is also proposed as a target for gene therapy.[5] Fragile X syndrome and Huntington's disease are two such disorders and diseases where CPEB regulation has been used to attempt recovery of brain function. There is not a cure for either of these afflictions, but translation dysfunction of CPEB proteins can be a cause for either.[16] When modeling fragile X syndrome in mice, CPEB1 gene mutations reduced pathological processes associated with the disorder.[17] A decrease in CPEB1 restored the balance of mRNA translation, which can be achieved by manipulating levels of miRNAs.
For Huntington's disease, a study on a Drosophila cell culture showed that the Drosophila Orb2A protein was absorbed on the surface of Huntingtin gene (Htt) aggregates.[16] The aggregates lead to a protein synthesis imbalance, cell decay, and neuron death. The absorption of the protein caused a partial reduction of the lethality of the Htt aggregates. The aggregates did not decrease, but protein synthesis balance was restored in the cells. However, CPEB sequestration translation dysfunction is not a definite cause of Huntington's disease symptoms in humans. Other RNA binding proteins could be other possible targets for translation dysfunction in patients with this disease.
Role in Oogenesis and Embryonic Development
[edit]CPEBs are responsible for the polyadenine tail length in oocytes during oogenesis. In Xenopus and mice oocytes, CPEB has been noted to control oocyte growth. Regulation of follicle development has been noted specifically in mice.[18] CPEB regulates oocyte development and follicle development in the dictyate stage through phosphorylation and dephosphorylation.[19] During pachytene, CPEB is phosphorylated, which controls polyadenylation and translation of mRNAs.[2] An experiment was conducted to determine how CPEB affected development by inhibiting the protein in mice. It was found that CPEB regulates Gdf9, a growth factor necessary for follicle development. Without CPEB, Gdf9 had a shortened polyadenine tail and reduced expression. It was also found that progressive oocyte loss and infertility arose from the knockdown of CPEB in oocytes, which resembles premature ovarian failure syndrome in humans.[19]
Role in Cellular Senescence
[edit]CPEB has been found to help regulate cellular senescence through modulating p53 mRNA polyadenylation-induced translation.[20] When human skin and lung cells were put under a knockdown of CPEB, they bypassed the M1 crisis stage of senescence. This bypass is required for cellular transformation. Reduced CPEB levels also affected the rate at which cell division occurred, slowing down the process until the cells ceased to divide. In mice, reduced CPEB levels caused cells to become immortal.[20] A senescence-like phenotype recurred when CPEB was introduced into early passage cells, but not late passage cells. Senescence is considered an irreversible process, but the CPEB-induced senescence-like phenotype can possibly refute that. CPEB is thus shown to regulate senescence, as well as mediate immortalization in cells.
References
[edit]- ^ a b c Hake, L.E.; Richter, J.D. (1994). "CPEB is a specificity factor that mediates cytoplasmic polyadenylation during Xenopus oocyte maturation". Cell. 79 (4): 617–627. doi:10.1016/0092-8674(94)90547-9. PMID 7954828.
- ^ a b Kim, Jong Heon; Richter, Joel D. (2010-01-01), Bradshaw, Ralph A.; Dennis, Edward A. (eds.), "Chapter 278 - Signaling to Cytoplasmic Polyadenylation and Translation", Handbook of Cell Signaling (Second Edition), San Diego: Academic Press, pp. 2317–2321, doi:10.1016/b978-0-12-374145-5.00278-3, ISBN 978-0-12-374145-5, retrieved 2023-11-28
- ^ De Moor, C.H.; Richter, J.D. (1999). "Cytoplasmic polyadenylation mediate masking and unmasking of cyclin B1 mRNA". EMBO J. 18 (8): 2294–2303. doi:10.1093/emboj/18.8.2294. PMC 1171312. PMID 10205182.
- ^ Mendez, R.; Barnard, D.; Richter, J.D. (2002). "Differential mRNA translation and meiotic progression require Cdc2-mediated CPEB destruction". EMBO J. 21 (7): 1833–1844. doi:10.1093/emboj/21.7.1833. PMC 125948. PMID 11927567.
- ^ a b c Kozlov, Eugene; Shidlovskii, Yulii V.; Gilmutdinov, Rudolf; Schedl, Paul; Zhukova, Mariya (2021-03-31). "The role of CPEB family proteins in the nervous system function in the norm and pathology". Cell & Bioscience. 11 (1): 64. doi:10.1186/s13578-021-00577-6. ISSN 2045-3701. PMC 8011179. PMID 33789753.
{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link) - ^ Luitjens, C; Gallegos, M; Kraemer, B; Kimble, J; Wickens, M (2000). "CPEB proteins control two key steps in spermatogenesis in C. elegans". Genes Dev. 14 (20): 2596–609. doi:10.1101/gad.831700. PMC 316992. PMID 11040214.
- ^ Kang, MK; Han, SJ (March 2011). "Post-transcriptional and post-translational regulation during mouse oocyte maturation". BMB Rep. 3. 44 (3): 147–157. doi:10.5483/BMBRep.2011.44.3.147. PMID 21429291. Archived from the original on 2013-11-02. Retrieved 2013-12-07.
- ^ Gilbert, Scott (2010). Developmental Biology. Sunderland, MA: Sinauer Associates, Inc. p. 60. ISBN 978-0-87893-384-6.
- ^ Kozak, Marilyn (1 November 2008). "Faulty old ideas about translational regulation paved the way for current confusion about how microRNAs function". Gene. 2. 423 (2): 108–115. doi:10.1016/j.gene.2008.07.013. PMID 18692553.
- ^ a b Lin, Chien-Ling; Evans, Veronica; Shen, Shihao; Xing, Yi; Richter, Joel D. (2010-02). "The nuclear experience of CPEB: Implications for RNA processing and translational control". RNA. 16 (2): 338–348. doi:10.1261/rna.1779810. ISSN 1355-8382. PMC 2811663. PMID 20040591.
{{cite journal}}: Check date values in:|date=(help)CS1 maint: PMC format (link) - ^ Giangarrà, Valeria; Igea, Ana; Castellazzi, Chiara Lara; Bava, Felice-Alessio; Mendez, Raul (2015-09-23). Jan, Eric (ed.). "Global Analysis of CPEBs Reveals Sequential and Non-Redundant Functions in Mitotic Cell Cycle". PLOS ONE. 10 (9): e0138794. doi:10.1371/journal.pone.0138794. ISSN 1932-6203. PMC 4580432. PMID 26398195.
{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link) - ^ Duran-Arqué, Berta; Cañete, Manuel; Castellazzi, Chiara Lara; Bartomeu, Anna; Ferrer-Caelles, Anna; Reina, Oscar; Caballé, Adrià; Gay, Marina; Arauz-Garofalo, Gianluca; Belloc, Eulalia; Mendez, Raúl (2022-09-12). "Comparative analyses of vertebrate CPEB proteins define two subfamilies with coordinated yet distinct functions in post-transcriptional gene regulation". Genome Biology. 23 (1): 192. doi:10.1186/s13059-022-02759-y. ISSN 1474-760X.
{{cite journal}}: CS1 maint: unflagged free DOI (link) - ^ Afroz, Tariq; Skrisovska, Lenka; Belloc, Eulàlia; Guillén-Boixet, Jordina; Méndez, Raúl; Allain, Frédéric H.-T. (2014-07-01). "A fly trap mechanism provides sequence-specific RNA recognition by CPEB proteins". Genes & Development. 28 (13): 1498–1514. doi:10.1101/gad.241133.114. ISSN 0890-9369. PMID 24990967.
- ^ a b Hake, Laura E.; Mendez, Raul; Richter, Joel D. (1998-02-01). "Specificity of RNA Binding by CPEB: Requirement for RNA Recognition Motifs and a Novel Zinc Finger". Molecular and Cellular Biology. 18 (2): 685–693. doi:10.1128/MCB.18.2.685. ISSN 1098-5549. PMC 108779. PMID 9447964.
{{cite journal}}: CS1 maint: PMC format (link) - ^ Parras, Alberto; Anta, Héctor; Santos-Galindo, María; Swarup, Vivek; Elorza, Ainara; Nieto-González, José L.; Picó, Sara; Hernández, Ivó H.; Díaz-Hernández, Juan I.; Belloc, Eulàlia; Rodolosse, Annie; Parikshak, Neelroop N.; Peñagarikano, Olga; Fernández-Chacón, Rafael; Irimia, Manuel (2018-08-15). "Autism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-splicing". Nature. 560 (7719): 441–446. doi:10.1038/s41586-018-0423-5. ISSN 0028-0836. PMC 6217926. PMID 30111840.
{{cite journal}}: CS1 maint: PMC format (link) - ^ a b Joag, Hiranmay; Ghatpande, Vighnesh; Desai, Meghal; Sarkar, Maitheli; Raina, Anshu; Shinde, Mrunalini; Chitale, Ruta; Deo, Ankita; Bose, Tania; Majumdar, Amitabha (2020-09-01). "A role of cellular translation regulation associated with toxic Huntingtin protein". Cellular and Molecular Life Sciences. 77 (18): 3657–3670. doi:10.1007/s00018-019-03392-y. ISSN 1420-9071.
- ^ Udagawa, Tsuyoshi; Farny, Natalie G; Jakovcevski, Mira; Kaphzan, Hanoch; Alarcon, Juan Marcos; Anilkumar, Shobha; Ivshina, Maria; Hurt, Jessica A; Nagaoka, Kentaro; Nalavadi, Vijayalaxmi C; Lorenz, Lori J; Bassell, Gary J; Akbarian, Schahram; Chattarji, Sumantra; Klann, Eric (2013-10-20). "Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiology". Nature Medicine. 19 (11): 1473–1477. doi:10.1038/nm.3353. ISSN 1078-8956. PMC 3823751. PMID 24141422.
{{cite journal}}: CS1 maint: PMC format (link) - ^ Conti, Marco; Franciosi, Federica (2018-05-01). "Acquisition of oocyte competence to develop as an embryo: integrated nuclear and cytoplasmic events". Human Reproduction Update. 24 (3): 245–266. doi:10.1093/humupd/dmx040. ISSN 1355-4786. PMC 5907346. PMID 29432538.
{{cite journal}}: CS1 maint: PMC format (link) - ^ a b Racki, Waldemar J.; Richter, Joel D. (2006-11-15). "CPEB controls oocyte growth and follicle development in the mouse". Development. 133 (22): 4527–4537. doi:10.1242/dev.02651. ISSN 1477-9129.
- ^ a b Burns, David M.; Richter, Joel D. (2008-12-15). "CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation". Genes & Development. 22 (24): 3449–3460. doi:10.1101/gad.1697808. ISSN 0890-9369. PMC 2607074. PMID 19141477.
{{cite journal}}: CS1 maint: PMC format (link)
Hello. Thank you for your contributions to Wikipedia. I noticed that one or more recent edit(s) you made did not have an edit summary. You can use the edit summary field to explain your reasoning for an edit, or to provide a description of what the edit changes. Summaries save time for other editors and reduce the chances that your edit will be misunderstood. For some edits, an adequate summary may be quite brief.
The edit summary field looks like this:
Edit summary (Briefly describe your changes)
Please provide an edit summary for every edit you make. With a Wikipedia account you can give yourself a reminder to add an edit summary by setting Preferences → Editing → 
Prompt me when entering a blank edit summary, and then click the "Save" button.
Thanks!